Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
addendum, adjudicated, adult, alanine, ALP, alpha, ALT, aminotransferase, API, Arena, ARR, ascertain, aspartate, AST, authentication, axonal, bamlanivimab, batch, Benchmark, Biden, bioavailability, BioCentury, bioequivalence, Brequinar, Bruton, BTK, bulbar, cap, cerebrospinal, choice, CI, cleaving, cognitive, comorbidity, compactor, cope, coping, cough, Coventry, COVID, cranial, crime, CRO, CRP, CUA, customarily, cyber, cybersecurity, dangerously, decade, deep, default, depressed, digit, dissipate, dried, dyspnea, EIB, electrodiagnostic, elevated, Eli, email, EMD, endopeptidase, envisaged, EUA, Evobrutinib, expectoration, facial, fatigue, FBI, fenebrutinib, fever, FTSE, fuller, GBS, glenn, globulin, grantee, granulation, Hansa, Hella, hematological, hepatotoxicity, hoc, humoral, ICU, IFN, Imlifidase, immunoglobulin, incapacity, indemnity, intensify, intercept, interfered, interval, intrusion, invasive, invoicing, IONIC, IP, IVIg, JD, Kohlhof, lesion, Lilly, Linkbase, loan, longitudinal, marketplace, MBA, McGrogan, MD, merge, missing, Moderna, MSA, Muehler, mutant, myalgia, nasopharyngeal, NBI, neuraminidase, neurofilament, neuroprotective, neutralizing, NHS, ocrelizumab, ofatumumab, ordinal, Oseltamivir, overreacting, pandemic, pattern, polymerase, polyradiculopathy, PP, precautionary, predictor, preparatory, prepayment, prognostic, proinflammatory, quantify, ramped, RCP, reaction, readout, recognizable, reconstitution, regular, remdesivir, repaid, repressed, Republic, respiratory, risky, robust, roller, rollout, ROR, ROTH, run, scenario, Schema, Sejvar, sequence, Serono, siponimod, speed, spray, spread, strongly, style, subacute, Sun, swab, Tamiflu, Taxonomy, tendon, thought, threat, thymoma, tied, TNF, unbilled, unclear, unnecessary, unprecedented, upcoming, upper, usable, variant, Veklury, ventilation, verify, version, vi, virology, walking, Warwickshire, wave, weaker, wet, whaley, XBRL, Xiong
Removed:
abroad, accident, advisor, attestation, banking, calling, cancellation, Cantor, Codification, collection, College, condensed, deficiency, detected, Diego, discontinue, discontinued, doubt, explain, Fitzgerald, forfeiture, hiring, input, interfere, IRC, leasing, notified, outlined, package, planning, principle, quickly, remove, replaced, resubmission, retained, retrospective, San, secret, secrete, secure, senior, simplified, steroid, strain, subset, transition, uncontrolled, unpatented, utilize
Filing tables
Filing exhibits
Related press release
IMUX similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S‑3 (File No. 333‑225230 and 333-250083), Form S‑4 (File No. 333‑229510), and Form S-8 (File No. 333‑233864) of Immunic, Inc. of our report dated February 26, 2021, relating to the consolidated financial statements of Immunic, Inc., which appears in this annual report on Form 10-K for the year ended December 31, 2020.
/s/ Baker Tilly US, LLP
Minneapolis, Minnesota
February 26, 2021